Patent details

EP3215132 Title: AMANTADINE FOR IMPROVING GAIT IN MULTIPLE SCLEROSIS

Basic Information

Publication number:
EP3215132
PCT Application Number:
US2015058872
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP158575910
PCT Publication Number:
WO2016073510
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
AMANTADINE FOR IMPROVING GAIT IN MULTIPLE SCLEROSIS
French Title of Invention:
AMANTADINE POUR L'AMÉLIORATION DE LA MARCHE DANS LA SCLÉROSE EN PLAQUE
German Title of Invention:
AMANTADIN ZUR VERBESSERUNG DES GANGS BEI MULTIPLER SKLEROSE
SPC Number:

Dates

Filing date:
03/11/2015
Grant date:
27/01/2021
EP Publication Date:
13/09/2017
PCT Publication Date:
12/05/2016
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
27/01/2021
EP B1 Publication Date:
27/01/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
03/11/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
20/01/2021
 
 

Name:
Adamas Pharmaceuticals, Inc.
Address:
1900 Powell Street, Suite 750, Emeryville, CA 94608, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
19/04/2021
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
WENT, Gregory T.
Address:
United States (US)

2

Name:
CHERNOFF, David
Address:
United States (US)

3

Name:
NGUYEN, Jack
Address:
United States (US)

4

Name:
FULTZ, Timothy J.
Address:
United States (US)

Priority

Priority Number:
201462075137 P
Priority Date:
04/11/2014
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/48; A61K 9/50; A61K 31/13; A61P 21/00;

Publication

European Patent Bulletin

1

Issue number:
202104
Publication date:
27/01/2021
Description:
Grant (B1)

2

Issue number:
202109
Publication date:
03/03/2021
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
01/12/2025
Annual Fee Number:
11
Annual Fee Amount:
148 Euro
Expected Payer:
Last Annual Fee Payment Date:
25/10/2024
Last Annual Fee Paid Number:
10
Last Annual Fee Paid Amount:
131 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
19/04/2021 Power Of Attorney 1
19/04/2021 Outgoing Correspondence 1